Which has grown faster, BSX or MRNA?

Over the past five years, MRNA grew revenue faster — BSX at a 13.40% CAGR versus MRNA at 19.33%.

Is BSX or MRNA more profitable?

BSX runs the higher net margin — BSX at 17.47% versus MRNA at -141.43%.

How have BSX and MRNA total returns compared?

Over the past 5 years, BSX delivered 7.97% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Boston Scientific Corporation and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$77.31B

$52.01HealthcareDelayed quote: Aug 19, 2026, 4:00 PM EDT

MRNA

Moderna, Inc.

$69.19B

$174.38HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — BSX vs MRNA

growth of $100 · dividends reinvested · last 8y

BSX +40.4% (+4.3%/yr)MRNA +837.5% (+32.3%/yr)MRNA compounded faster over this window

Log scale — wide-divergence pair

BSX MRNA

BSX vs MRNA: by the numbers

•BSX is the larger company ($77.31B vs $69.19B market cap).
•BSX is profitable (17.47% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 13.40% CAGR).

Metrics side by side

Valuation

Metric	BSX	MRNA
P/E ratio	21.14	N/A
Forward P/E	15.74	N/A
P/S ratio	3.68	30.99
P/B ratio	3.10	10.21
EV / EBITDA	15.41	N/A
FCF yield	4.69%	N/A

Profitability

Metric	BSX	MRNA
Gross margin	71.16%	55.35%
Operating margin	21.46%	-158.13%
Net margin	17.47%	-141.43%
ROE	14.71%	-46.61%
ROIC	10.57%	-39.16%

Growth (annualized)

Metric	BSX	MRNA
Revenue CAGR (5Y)	13.40%	19.33%
FCF CAGR (5Y)	15.64%	N/A
Total return CAGR (5Y)	3.28%	-14.22%

Frequently asked

Which has grown faster, BSX or MRNA?: Over the past five years, MRNA grew revenue faster — BSX at a 13.40% CAGR versus MRNA at 19.33%.
Is BSX or MRNA more profitable?: BSX runs the higher net margin — BSX at 17.47% versus MRNA at -141.43%.
How have BSX and MRNA total returns compared?: Over the past 5 years, BSX delivered 7.97% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Boston Scientific ROE Moderna ROE Boston Scientific operating margin Moderna operating margin Boston Scientific revenue growth Moderna revenue growth Boston Scientific free cash flow Moderna free cash flow

Boston Scientific & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.